Variant report
Variant | esv2763496 |
---|---|
Chromosome Location | chr5:120061067-120071855 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566653154 | chr5:120061091-120061092 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115157482 | chr5:120061107-120061108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532385468 | chr5:120061153-120061154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73265938 | chr5:120061163-120061164 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs112716320 | chr5:120061186-120061187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs113028471 | chr5:120061187-120061188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189969142 | chr5:120061194-120061195 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6872181 | chr5:120061207-120061208 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs542636157 | chr5:120061318-120061319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372784899 | chr5:120061340-120061341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140734933 | chr5:120061346-120061347 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540026609 | chr5:120061417-120061418 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149792598 | chr5:120061421-120061422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532236986 | chr5:120061459-120061460 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs73265939 | chr5:120061471-120061472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562491103 | chr5:120061552-120061553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145779107 | chr5:120061565-120061566 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548576423 | chr5:120061624-120061625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182886219 | chr5:120061635-120061636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148454739 | chr5:120061642-120061643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552762487 | chr5:120061656-120061657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571046870 | chr5:120061667-120061668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1839247 | chr5:120061697-120061698 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs142591623 | chr5:120061698-120061699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552699097 | chr5:120061705-120061706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187437434 | chr5:120061715-120061716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111600838 | chr5:120061763-120061764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141079261 | chr5:120061789-120061790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs34406740 | chr5:120061820-120061821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112332154 | chr5:120061832-120061833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1839246 | chr5:120061858-120061859 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs193298926 | chr5:120061861-120061862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114565841 | chr5:120061884-120061885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544034839 | chr5:120061888-120061889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs562603840 | chr5:120061897-120061898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530021650 | chr5:120061978-120061979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183818658 | chr5:120061986-120061987 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560545716 | chr5:120062003-120062004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112046538 | chr5:120062014-120062015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187624945 | chr5:120062038-120062039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570985663 | chr5:120062124-120062125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs116555157 | chr5:120062136-120062137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534604205 | chr5:120062142-120062143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs568633522 | chr5:120062169-120062170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192056985 | chr5:120062253-120062254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554228669 | chr5:120062268-120062269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144907666 | chr5:120062289-120062290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78997447 | chr5:120062315-120062316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184418265 | chr5:120062388-120062389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146659361 | chr5:120062432-120062433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:120045800-120061600 | Weak transcription | HSMM | muscle |
2 | chr5:120060800-120063200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr5:120061000-120061200 | Enhancers | Aorta | Aorta |
4 | chr5:120061000-120062400 | Enhancers | Brain Germinal Matrix | brain |
5 | chr5:120061200-120067000 | Weak transcription | Aorta | Aorta |
6 | chr5:120061600-120062200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
7 | chr5:120061600-120062600 | Enhancers | HSMM | muscle |
8 | chr5:120061800-120062200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr5:120061800-120062400 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr5:120064800-120065000 | Enhancers | HSMM | muscle |
11 | chr5:120069600-120070200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr5:120069600-120070200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr5:120069600-120070200 | Enhancers | HSMMtube | muscle |
14 | chr5:120069600-120070800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr5:120069600-120071000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
16 | chr5:120069600-120071000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr5:120069600-120071000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
18 | chr5:120069800-120070200 | Enhancers | H1 Cell Line | embryonic stem cell |
19 | chr5:120069800-120070200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
20 | chr5:120070400-120071000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
21 | chr5:120071800-120072200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |